Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Lansen Pharmaceutical Holdings

Lansen Pharmaceutical Holdings
2001 FOUNDED
PUBLIC STATUS
501-600 EMPLOYEES
00503 STOCK SYMBOL
2 INVESTMENTS
$0.09 SHARE PRICE (As of Thursday Closing)
Description

Lansen Pharmaceutical Holdings Ltd is an investment holding company engaged in research and development, production and sales of natural drugs, traditional Chinese medicines and chemical drugs. Its key products are involved in the department of rheumatism, department of dermatology, medical beauty, diagnostic reagents, and other fields. The operating segments of the group are Pharmaceuticals, Medical cosmetics products, and Healthcare products. It generates a majority of revenue from the Pharmaceuticals segment, which includes development, production, and sale of specialty pharmaceuticals mainly used in the field of rheumatology and dermatology and other pharmaceuticals. The group operates in the PRC and internationally, of which prime revenue is derived from the operations in PRC.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Holding Companies
Other Industries
Biotechnology
Pharmaceuticals
Stock Exchange
HKG
Primary Office
  • 12/F., Li Po Chun Chambers
  • Suites 1203-4, 189 Des Voeux Road
  • Central
  • Hong Kong

+852 2828 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Lansen Pharmaceutical Holdings’s full profile, request a free trial.

Lansen Pharmaceutical Holdings Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.08 - $0.14 $35.7M $0.09 -$0.01 320K 397M

Lansen Pharmaceutical Holdings Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 130,138 120,631 148,481 175,914
Revenue 47,105 56,872 89,484 94,824
EBITDA 341 9,421 23,988 13,223
Net Income (5,663) 160 15,629 3,836
Total Assets 213,303 201,913 227,745 222,762
Total Debt 95,416 87,224 99,135 105,098
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lansen Pharmaceutical Holdings Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 31-Dec-2018 000000000 00000000 00.000 Other Commercial Services
Zhejiang Starry Pharmaceutical Company 01-Jan-2010 Corporate 000.00 Pharmaceuticals
To view this company’s complete investment and acquisition history, request access »